
Novonix Limited
Novonix Limited (NVX) Free Cash Flow & Analysis
Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.
NVX · free cash flow · updated Jun 8, 2026
Core FCF metrics
NVX · FCF · TTM · margin & CAGRFree cash flow was −$102.4M for FY2025 (fiscal year ending 2025-12-31), down 45.7% year-over-year
Annual free cash flow history
Annual free cash flow data
FCF valuation metrics
NVX · P/FCF · FCF yield · FCF per shareNovonix Limited (NVX) reported negative free cash flow of −$0.10B. FCF-based valuation ratios are not meaningful when FCF is negative.
FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.
Cash flow statement summary
NVX · cash flow statement · operating / investing / financingFor FY2025, Novonix Limited generated −$42.2M in operating cash flow and spent 60M in capital expenditures, yielding −$102.4M in free cash flow.
For the complete Operating / Investing / Financing line-item breakdown:
View Full Cash Flow Statement →Free cash flow vs peers (Industrials)
About Free Cash Flow & Methodology
Novonix Limited (NVX) reported free cash flow of −$102.4M for FY2025 (fiscal year ending 2025-12-31), down 45.7% year-over-year.
Novonix Limited has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 12 fiscal years.
Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.
Frequently asked questions
NVX free cash flow · 8 questionsNovonix Limited free cash flow was −$102.4M for FY2025, down 45.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$172.6M.
▸ Source: FMP /cash-flow-statement · US GAAP · Novonix Limited · Novonix Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026